PD/AD wurpel Flashcards
Benzotropine MOA and anticholinergics ADR
M1 antagonist
constipation, dry mouth, nausea,
urinary retention, tachycardia, and blurred
vision. Hyperthermia and paralytic ileus
Dopa info
L-DOPA -precursor to dopamine. Converted to dopamine by DOPA; periphery most l-DOPA degraded
DA in periphery has GI and CV effects
Carbidopa and Benzserazide
do not cross BBB, inhibit peripheral conversion of l-DOPA to DA, allows
reduction of dose
What can pramipexole cause ?
Sleep attacks, compulsive behaviors and pathologic gambling
What can ropinirole cause ?
Hallucinations
Rotigotine MOA and SE
D2 agonist in caudate-putamen (10-fold selectivity for the D3 receptor over the D2).
Psychological SE/ADR
Apomorphine MOA
nonselective DA agonist, DA2 > DA1
Tolcapone
COMT inhibitor liver tox NO
Entacapone MOA
COMT inhibitor, does not cross BBB
Selegeline / Rasigaline MOA
MAO-B inhibitor
Amantadine MOA
NMDA antag, DA rel & blocks reuptake
Pimavanserin MOA
5-HT2A inverse agonist
Opicapone
qD HS
Huntingtons chorea meds and dosing
Tetrabenazine (Xenazine) t1/2~5-6 hr
Deutetrabenazine (Austedo) t1/2~17hr, qD dosing
Alzheimers meds and association
- Tacrine (Cognex) - AchEI & BuChEI
- Donepezil (Aricept) - AchEI
- Rivastigmine - AchEI & BuChEI
- Galantamine (Razadyne, Reminyl) - AchEI & allosteric nicotinic modulation - dual mechanism of action
- Memantine - uncompetitive (open-channel) NMDA receptor antagonist, preventing glutamate
action on this receptor. Memantine has a preference for the NMDA receptor-operated cation channels